| Edition |
2nd ed. |
| Physical description |
1 online resource (xxiii, 363 pages) : illustrations (some color) |
| Bibliography |
Includes bibliographical references and index. |
| Contents |
Cover -- Preface -- Table of Contents -- Part I Basics -- 1 The Changing Epidemiology of Thyroid Cancer -- 1.1 Basic Epidemiological Problems in Thyroid Cancer -- 1.2 General Epidemiological Data for Thyroid Cancer -- 1.3 Prognosis -- 1.4 Thyroid Malignancy Entities with Special Features -- 1.4.1 Papillary Microcarcinoma -- 1.4.2 Hèurthle Cell Carcinoma -- 1.4.3 Histological Variants of Papillary Thyroid Cancer -- 1.4.4 Poorly Differentiated (Insular) Thyroid Carcinoma -- 1.4.5 Anaplastic Carcinoma -- 1.4.6 Medullary Thyroid Carcinoma -- 1.4.7 Thyroid Lymphoma -- 1.4.8 Secondary Tumors -- 1.5 Changes in Epidemiology -- 1.6 Summary -- References -- 2 Histopathology, Immunohistochemistry, and Molecular Biology -- 2.1 Introduction -- 2.2 Principles of Histopathological Diagnosis and Classification -- 2.3 Histopathology and Prognosis -- 2.4 Histo/Cytopathology in Preoperative and Intraoperative Diagnosis (Problem of Frozen Section) -- 2.5 Auxiliary Techniques (Cytometry, Immunohistochemistry, Molecular Pathology) -- 2.6 Preoperative Diagnosis (Fine Needle Aspiration Biopsy) -- 2.7 Prognosis -- 2.8 Pathogenesis -- References -- 3 Familial Differentiated Carcinoma of the Thyroid -- 3.1 Introduction -- 3.2 Etiology of Non-Medullary Thyroid Cancers -- 3.3 Could Familial Thyroid Cancers Be a Chance Finding? -- 3.4 Genetics and Associated Syndromes -- 3.5 Clinical Implications of Familial Nonmedullary Thyroid Cancer -- References -- 4 The Diagnosis of Thyroid Cancer -- 4.1 Prevalence/Risk Assessment -- 4.2 Findings/Symptoms -- 4.3 Ultrasonography -- 4.4 Scintigraphy -- 4.5 Fine-Needle Aspiration Biopsy -- 4.6 Additional Diagnostic Procedures -- References -- 5 The Current Surgical Approach to Non-Medullary Thyroid Cancer -- 5.1 Introduction -- 5.2 Prognostic Factors -- 5.3 Surgical Treatment -- References -- Part II Differentiated Thyroid Cancer -- 6 Radioiodine Therapy for Thyroid Cancer -- 6.1 Introduction -- 6.2 Radioiodine Ablation and Radioiodine Therapy -- 6.2.1 Ablation of Residual Thyroid Tissue -- 6.2.2 Ablative Dose -- 6.2.3 In Which Patients Is Ablation Unnecessary? -- 6.2.4 Radioiodine Therapy for Thyroid Cancer -- 6.2.5 Radioiodine Therapy with Negative Radioiodine Scan -- 6.2.6 Radioiodine Therapy in Patients on Maintenance Hemodialysis -- 6.3 Prognostic Factors and Therapeutic Strategies in Metastatic Thyroid Cancer -- 6.3.1 Lymph Node Metastases -- 6.3.2 Pulmonary Metastases -- 6.3.3 Bone Metastases -- 6.3.4 Brain Metastases -- 6.3.5 Locally Invasive Thyroid Cancer -- 6.4 Optimizing the Therapeutic and Diagnostic Capabilities of 131I -- 6.4.1 Thyroid-Stimulating Hormone Stimulation -- 6.4.2 Administration of Recombinant Human Thyrotropin . -- 6.4.3 Low-Iodine Diet -- 6.4.4 Optimal Diagnostic Scan Dose -- 6.4.5 Redifferentiation Therapy and Future Therapeutic Options -- 6.4.6 Lithium -- 6.4.7 Further Optimization of 131I Imaging -- 6.4.8 Diuretic-Enhanced 131I Clearance -- 6.5 Side Effects of 131I Therapy -- 6.5.1 Radiation Thyroiditis -- 6.5.2 Painless Neck Edema -- 6.5.3 Sialadenitis -- 6.5.4 Taste Dysfunction -- 6.5.5 Gastrointestinal Sympt. |
| Summary |
One of the main reasons for publishing this second edition of?T- roid Cancer? is the fact that the first edition has sold out. Furth- more, during the 4 years following the publication of the first edition in 2001, some progress, mainly in the basic sciences (molecular biology), has been made. The most prominent change in the clinical sciences has been the new classification of thyroid cancer, especially with relation to T1-T3 tumors. Now, tumors with a diameter of up to 2 cm are still classified T1. This new UICC classification (6th edition) follows the classification of the American Society of Pathology. These changes require a modification of the old guidelines. According to the Hedinger classification (1988) tumors with a diameter below 1 cm were classified as?papillary microcarcinoma of the thyroid?. Only in those tumors was total or nearly total thyroidectomy deemed unn- essary and I-131 therapy not a prerequisite for treatment. The majority of the chapters has been updated including references to many new publications. Two new chapters, on I-124 PET and - simetry, have been added. We strongly feel that this second edition of?Thyroid Cancer? is again a state-of-the-art overview of the diagnosis and treatment of thyroid cancer. Bonn, Frankfurt am Main H.-J. Biersack, F. Grünwald Preface to the First Edition Thyroid cancer was first described at the end of the eighteenth c- tury. |
| Language notes |
English. |
| Notes |
Springer eBooks |
| Other author |
Biersack, H. J.
|
|
Grünwald, F.
|
| Subject |
Thyroid gland -- Cancer.
|
| ISBN |
9783540223092 (alk. paper) |
|
3540223096 (alk. paper) |
|
3540278451 (electronic bk.) |
|
9783540278450 (electronic bk.) |
|
6610235201 |
|
9786610235209 |
|
1280235209 |
|
9781280235207 |
| Standard Number |
10.1007/3-540-27845-1 |
|
